Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Zhong Nora
@tapdataldp· 3 followers
Launched
3y ago
2023-08-17 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending

Marketing moves

Launches, search & content, referrals, promotions
X accounts@tapdataldp
  • Launched on Product HuntLaunch

    Real Time Data Pipelines & Data Hub

    Aug 17, 2023 · 3y agoLaunch page

Open Source & Agent Ecosystem

GitHub · MCP / Skill
Last commit 2026-11-06
GitHub Stars
★ 72
Forks
9
License
SSPL-1.0
Primary language
Go

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search32%
  • Referrals10%
  • Social6%
  • Other12%

Countries

  • United States59%
  • India36%
  • Vietnam6%

Search

Domain authority —Domain registered 2017-11-30

KeywordMonthly volume
oltp16.9K
oltp vs olap7,600
materialized view2,110
oltp and olap1,490
mongodb topdata150

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2023-08-17

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Tapdata get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Tapdata and what platforms does it support?
Tapdata is catalogued under Data Integration & Warehousing: The Real-Time Backbone of Modern Data Infrastructure. Supported platforms: CLI / SDK.
Is Tapdata open source?
Tapdata has a public repository (https://github.com/tapdata/tapdata) under the SSPL-1.0 license, recording 72 GitHub stars.Source

Related products in this category

Data & Analytics / Data Integration & Warehousing

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.